These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 131480)

  • 21. Anticholinergic drugs in the treatment of airways disease.
    Mann JS; George CF
    Br J Dis Chest; 1985 Jul; 79(3):209-28. PubMed ID: 2861843
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of ipratropium bromide on lung mechanics in patients with irreversible airway obstruction. An indirect approach.
    Hawrylkiewicz I; Gluskowski J; Zieliński J
    Eur J Respir Dis; 1981; 62(2):142-3. PubMed ID: 6453720
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
    Kaik G; Kaik B; Laggner A
    Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of an adrenergic-parasympatholytic aerosol combination on the respiratory function].
    Rossi A; Rampulla C; Nascimbene T; Casali L
    Minerva Med; 1979 Jan; 70(4):333-46. PubMed ID: 155228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol.
    Ashutosh K; Lang H
    Ann Allergy; 1984 Nov; 53(5):401-6. PubMed ID: 6238558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Broncho-dilating effects of SCH 1000 in patients with spasmodic chronic bronchitis].
    Weitzenblum E; Rasaholinjanahary J
    Poumon Coeur; 1977; 33(4):219-24. PubMed ID: 144268
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticholinergic and beta-sympathomimetic inhalation challenges in asthma and bronchitis.
    Marcq M; Minette A
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):156-62. PubMed ID: 1016524
    [No Abstract]   [Full Text] [Related]  

  • 28. Bronchodilatory and circulatory effects of inhaling increasing doses of an anti-cholinergic drug, ipratropium bromide (SCH 1000).
    Simonsson BG; Jonson B; Ström B
    Scand J Respir Dis; 1975 Sep; 56(3):138-49. PubMed ID: 1162305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipratropium bromide and fenoterol in pulmonary tuberculosis.
    Salorinne Y; Poppius H; Stenius-Aarniala B
    Scand J Respir Dis Suppl; 1979; 103():183-5. PubMed ID: 155296
    [No Abstract]   [Full Text] [Related]  

  • 30. Ipratropium (atrovent) for airway obstruction.
    Drug Ther Bull; 1980 Jul; 18(15):59. PubMed ID: 6447586
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P; Ramos Martos A; Cabrera Moreno R; Luque Leal J; Palacios Giner A
    Rev Clin Esp; 1983 Nov; 171(4):265-8. PubMed ID: 6229844
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combined inhalation of salbutamol and ipratropin in chronic bronchial obstruction].
    Kok-Jensen A
    Ugeskr Laeger; 1979 Jul; 141(30):2039-41. PubMed ID: 161105
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of ipratropium bromide and salbutamol in a long-term trial in asthmatic and bronchitic patients in a cold climate.
    Laitinen LA; Poppius H; Haahtela T
    Scand J Respir Dis Suppl; 1979; 103():163-9. PubMed ID: 155293
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the bronchodilating effects of ipratropium bromidefenoterol in comparison with carbuterol].
    Mistretta A; Crimi N; Palermo F; Gibellino F; Distefano SM; Vancheri C
    Arch Monaldi; 1983; 38(5-6):273-8. PubMed ID: 6238582
    [No Abstract]   [Full Text] [Related]  

  • 35. A double blind cross-over study of maximal expiratory flows and arterial blood gas tensions in normals, asthmatics and bronchitics after salbutamol and ipratropin.
    Thiessen B; Pedersen OF
    Scand J Respir Dis Suppl; 1979; 103():170-7. PubMed ID: 155294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Sch 1000: a new anticholinergic bronchodilator.
    Segal MS
    Am Rev Respir Dis; 1976 Jun; 113(6):893. PubMed ID: 132884
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical pharmacology of a combination of bronchodilators.
    Casali L; Grassi C; Rampulla C; Rossi A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):277-80. PubMed ID: 157338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):395-408. PubMed ID: 4282560
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of bronchial obstruction with a combination of a selective beta adrenergic (fenoterol) and a cholinolytic agent (ipratropium)].
    Vondra V; Prazáková J; Felkel H; Tomíska F
    Vnitr Lek; 1981 Nov; 27(11):1078-85. PubMed ID: 6458940
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
    McIntosh D
    Pharmatherapeutica; 1986; 4(7):416-21. PubMed ID: 2938194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.